Literature DB >> 16399991

Severe bacteremia results in a loss of hepatic bacterial clearance.

Alix Ashare1, Martha M Monick, Linda S Powers, Timur Yarovinsky, Gary W Hunninghake.   

Abstract

RATIONALE: Although it has been postulated that liver injury results in impaired clearance of bacteria from the blood, no prior study has evaluated hepatic bacterial clearance during sepsis.
OBJECTIVES: We hypothesized that liver injury during the evolution of sepsis would result in impaired hepatic bacterial clearance.
METHODS: Mild and severe bacteremia were generated in C57BL/6 mice by low- and high-dose intratracheal inoculation with Pseudomonas aeruginosa.
MEASUREMENTS AND MAIN RESULTS: The mortality rates with mild and severe bacteremia were 20% and 60%, respectively. Hepatic bacterial clearance was preserved throughout the evolution of mild bacteremia but was lost late with severe bacteremia. The loss of hepatic bacterial clearance resulted in increased systemic bacteremia and mortality. Pretreatment with a caspase inhibitor resulted in preservation of hepatic bacterial clearance with severe bacteremia and eventual control of the bacteremia. When Kupffer cells were ablated before the onset of bacteremia, there was a loss of hepatic bacterial clearance. This converted an initially mild bacteremia into severe bacteremia with increased organ injury and mortality.
CONCLUSIONS: These observations suggest that hepatic bacterial clearance may be lost during the evolution of sepsis, resulting in a failure to control bacteremia. Thus, the capacity of the liver to clear bacteria is an important determinant of the outcome in sepsis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16399991      PMCID: PMC2662948          DOI: 10.1164/rccm.200509-1470OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  44 in total

1.  Modulation of airway inflammation and bacterial clearance by epithelial cell ICAM-1.

Authors:  Alicia L Humlicek; Liyi Pang; Dwight C Look
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-05-28       Impact factor: 5.464

2.  Blood cultures.

Authors:  M D Aronson; D H Bor
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

3.  Bacteremia in cirrhosis of the liver.

Authors:  N Graudal; N Milman; E Kirkegaard; B Korner; A C Thomsen
Journal:  Liver       Date:  1986-10

4.  Novel murine model of pneumococcal pneumonia: use of temperature as a measure of disease severity to compare the efficacies of moxifloxacin and levofloxacin.

Authors:  Darrin J Bast; M Yue; X Chen; D Bell; L Dresser; R Saskin; L A Mandell; D E Low; Joyce C S de Azavedo
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

5.  The prognostic significance of bacteremia in hepatic cirrhosis.

Authors:  N Graudal; B Hubeck; J Bonde; A C Thomsen
Journal:  Liver       Date:  1987-06

6.  Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis.

Authors:  A Rimola; R Soto; F Bory; V Arroyo; C Piera; J Rodes
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

7.  Predicting bacteremia in patients with community-acquired pneumonia.

Authors:  Mark L Metersky; Allen Ma; Dale W Bratzler; Peter M Houck
Journal:  Am J Respir Crit Care Med       Date:  2003-11-20       Impact factor: 21.405

8.  Kupffer cell depletion attenuates superoxide anion release into the hepatic sinusoids after lipopolysaccharide treatment.

Authors:  Masahiko Fukuda; Hirokazu Yokoyama; Takeshi Mizukami; Hideki Ohgo; Yukishige Okamura; Yoshitaka Kamegaya; Yoshinori Horie; Shinzo Kato; Hiromasa Ishii
Journal:  J Gastroenterol Hepatol       Date:  2004-10       Impact factor: 4.029

9.  Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis.

Authors:  Joel G R Weaver; Mark S Rouse; James M Steckelberg; Andrew D Badley
Journal:  FASEB J       Date:  2004-08       Impact factor: 5.191

10.  Akt decreases lymphocyte apoptosis and improves survival in sepsis.

Authors:  Ursula Bommhardt; Katherine C Chang; Paul E Swanson; Tracey H Wagner; Kevin W Tinsley; Irene E Karl; Richard S Hotchkiss
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

View more
  13 in total

1.  Chronic liver disease impairs bacterial clearance in a human model of induced bacteremia.

Authors:  Alix Ashare; Clark Stanford; Patricia Hancock; Donna Stark; Kathleen Lilli; Emily Birrer; Amanda Nymon; Kevin C Doerschug; Gary W Hunninghake
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

2.  Transcriptional induction of the Pseudomonas aeruginosa type III secretion system by low Ca2+ and host cell contact proceeds through two distinct signaling pathways.

Authors:  Nandini Dasgupta; Alix Ashare; Gary W Hunninghake; Timothy L Yahr
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

3.  Insulin-like growth factor-1 levels contribute to the development of bacterial translocation in sepsis.

Authors:  Gary W Hunninghake; Kevin C Doerschug; Amanda B Nymon; Gregory A Schmidt; David K Meyerholz; Alix Ashare
Journal:  Am J Respir Crit Care Med       Date:  2010-04-22       Impact factor: 21.405

4.  Insulin-like growth factor-1 improves survival in sepsis via enhanced hepatic bacterial clearance.

Authors:  Alix Ashare; Amanda B Nymon; Kevin C Doerschug; John M Morrison; Martha M Monick; Gary W Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2008-04-24       Impact factor: 21.405

5.  Morbidity associated with Pseudomonas aeruginosa bloodstream infections.

Authors:  Marc H Scheetz; Michael Hoffman; Maureen K Bolon; Grant Schulert; Wendy Estrellado; Ioannis G Baraboutis; Padman Sriram; Minh Dinh; Linda K Owens; Alan R Hauser
Journal:  Diagn Microbiol Infect Dis       Date:  2009-04-02       Impact factor: 2.803

6.  Dynamical system analysis of Staphylococcus epidermidis bloodstream infection.

Authors:  Hangyul M Chung; Megan M Cartwright; David M Bortz; Trachette L Jackson; John G Younger
Journal:  Shock       Date:  2008-11       Impact factor: 3.454

7.  The Efficacy of Posttreatment with Synthetic C-Reactive Protein in Murine Bacterial Peritonitis via Activation of FcγRI-Expressing Kupffer Cells.

Authors:  Manabu Kinoshita; Seigo Ito; Takuya Ishikiriyama; Kumiko Sekiguchi; Ryota Yamaguchi; Ryoichi Tsuruhara; Akihisa Matsuda; Kazuki Koiwa; Masahiro Nakashima; Hiroyuki Nakashima; Masao Miyashita; Shuhji Seki
Journal:  J Innate Immun       Date:  2021-05-04       Impact factor: 7.349

Review 8.  Neonatal liver failure: aetiologies and management--state of the art.

Authors:  Naresh P Shanmugam; Sanjay Bansal; Anne Greenough; Anita Verma; Anil Dhawan
Journal:  Eur J Pediatr       Date:  2010-10-02       Impact factor: 3.860

9.  Correlation of the expression of YY1 and Fas cell surface death receptor with apoptosis of peripheral blood mononuclear cells, and the development of multiple organ dysfunction in children with sepsis.

Authors:  Judith Reséndiz-Martínez; Juan Asbun-Bojalil; Sara Huerta-Yepez; Mario Vega
Journal:  Mol Med Rep       Date:  2017-03-09       Impact factor: 2.952

Review 10.  The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host.

Authors:  Eirini Christaki; Evangelos J Giamarellos-Bourboulis
Journal:  Virulence       Date:  2013-09-25       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.